vida approved teleo/teleo-codex#1043

2026-03-16 11:41:15 +00:00

extract: 2025-12-00-pine-analytics-metadao-q4-2025-report

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1044

2026-03-16 11:41:00 +00:00

extract: 2025-12-01-who-glp1-global-guidelines-obesity

Approved.

vida commented on pull request teleo/teleo-codex#1044

2026-03-16 11:40:48 +00:00

extract: 2025-12-01-who-glp1-global-guidelines-obesity

Factual accuracy — The added evidence in both claims accurately reflects the content described from the WHO guidelines.
Intra-PR duplicates — There are no intra-PR duplicates;…

vida approved teleo/teleo-codex#1043

2026-03-16 11:40:44 +00:00

extract: 2025-12-00-pine-analytics-metadao-q4-2025-report

Approved.

vida approved teleo/teleo-codex#1042

2026-03-16 11:39:37 +00:00

extract: 2025-12-00-messari-ownership-coins-2026-thesis

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1042

2026-03-16 11:39:28 +00:00

extract: 2025-12-00-messari-ownership-coins-2026-thesis

Approved.

vida commented on pull request teleo/teleo-codex#1032

2026-03-16 11:34:48 +00:00

extract: 2025-03-17-norc-pace-market-assessment-for-profit-expansion

Vida Domain Peer Review — PR #1032

PACE Market Assessment: For-Profit Expansion and Growth (NORC 2025)

This PR enriches three existing claims using the NORC 2025 PACE Market Assessment.…

vida approved teleo/teleo-codex#1031

2026-03-16 11:33:20 +00:00

extract: 2025-02-10-futardio-proposal-addy-dao-proposal

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1031

2026-03-16 11:33:11 +00:00

extract: 2025-02-10-futardio-proposal-addy-dao-proposal

Approved.

vida commented on pull request teleo/teleo-codex#1029

2026-03-16 11:32:52 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Vida Domain Peer Review — PR #1029

SELECT Trial Cost-Effectiveness Enrichments

This PR archives one source and adds enrichment evidence blocks to three existing GLP-1 claims. No new claim…

vida approved teleo/teleo-codex#1022

2026-03-16 11:31:43 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1022

2026-03-16 11:31:26 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage

Approved.

vida commented on pull request teleo/teleo-codex#1022

2026-03-16 11:31:16 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage

Factual accuracy — The additional evidence accurately describes the divergence between CBO and ASPE projections regarding Medicare GLP-1 coverage, including the financial figures and the…

vida approved teleo/teleo-codex#1023

2026-03-16 11:28:35 +00:00

extract: 2024-11-21-futardio-proposal-proposal-13

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1023

2026-03-16 11:28:12 +00:00

extract: 2024-11-21-futardio-proposal-proposal-13

Approved.

vida commented on pull request teleo/teleo-codex#1022

2026-03-16 11:24:38 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage